PDPK1 and medulloblastoma: Constitutively activated PDPK1 has been shown to stimulate β-catenin/ Wnt signaling in medulloblastoma where PDPK1 small molecule inhibition increased survival and enhanced the cytotoxic effects of chemotherapeutic drugs34.